Order Article Reprints

Bund V, Lecointre L, Velten M, Ouldamer L, Bendifallah S, Koskas M, Bolze P-A, Collinet P, Canlorbe G, Touboul C, et al. Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN). Journal of Clinical Medicine. 2020; 9(8):2427. https://doi.org/10.3390/jcm9082427

Bund, Virginie, Lise Lecointre, Michel Velten, Lobna Ouldamer, Sofiane Bendifallah, Martin Koskas, Pierre-Adrien Bolze, Pierre Collinet, Geoffroy Canlorbe, Cyril Touboul, and et al. 2020. "Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)" Journal of Clinical Medicine 9, no. 8: 2427. https://doi.org/10.3390/jcm9082427

Bund, V., Lecointre, L., Velten, M., Ouldamer, L., Bendifallah, S., Koskas, M., Bolze, P.-A., Collinet, P., Canlorbe, G., Touboul, C., Huchon, C., Coutant, C., Faller, E., Boisramé, T., Gantzer, J., Demarchi, M., Baldauf, J.-J., Ballester, M., Lavoué, V., & Akladios, C. (2020). Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN). Journal of Clinical Medicine, 9(8), 2427. https://doi.org/10.3390/jcm9082427